LEA suppresses NFATc1 expression by blocking both NF-κB and NFATc1-mediated transactivity. (A) BMMs were pre-treated with DMSO and LEA (10 μg/mL) for 1 h, and stimulated with RANKL for 0, 5, 15, and 30 min. The cells were lysed and immunoblotted with antibodies against p-Akt, Akt, p-ERK, ERK, p-IκB, IκB, p-p38, p38, p-JNK, and JNK. Band intensities were normalized to β-Actin control. (B) 293T cells were transiently transfected with the reporter plasmid Nfatc1-Luc along with c-Fos, p65, or Nfatc1 in the presence or absence of LEA (10 μg/mL). Luciferase activity was measured after 24 h post-transfection using Luciferase assay kit (Promega, Madison, WI, USA). Each bar represents the means ± S.D. of three independent experiments. *** p < 0.001. ns = not significant.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Int. J. Mol. Sci.
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.